From animal studies, other proposed anti-tumor mechanisms of probiotics have included greater regulation of Tregs or TGF-β and increased recruitment of Th17 via the CCL20/chemokine receptor 6 axes in metastatic disease, both mechanisms of which involve alterations to the tumor microenvironment [144, 145]. Here, TGFB1 is linked to neoplasm.